Agriculture must produce more food under hotter, drier, and more unpredictable climates. Veos is building the platform that makes crops resilient enough to do it.
Veos operates a climate-resilience platform powered by OliSignal™, our proprietary olive polyphenol signaling technology. Two integrated tracks: BioPropello™ primes existing crops this season; Veos Propello Genesis™ breeds new resilient strains of rice, coffee, and cacao for the seasons ahead.
Parsley cycle: d = 7.04, p < 10⁻¹³. Green-bean full cycle: 4.7× yield, 11 days earlier harvest, 100% vs 0% survival under stress. Cereals at Texas A&M: +35% corn, +49% sorghum germination. Real fields. Four countries. Cycles completed.
Climate change is rewriting the productivity ceiling of every major crop.
Heat, drought, and salinity now account for more than half of global crop yield losses. Arable land is degrading faster than it can be restored. Fertilizer overuse is a symptom, not a solution — stressed crops can't absorb inputs efficiently, so growers over-apply, driving costs up, margins down, and emissions higher.
The category has been waiting for an integrated platform that addresses this at both the treatment and genetic level — priming existing crops this season, while breeding permanently more resilient strains for the seasons ahead. That's what Veos built.
Veos Agriculture is a two-track climate-resilience platform powered by OliSignal™ — combining a treatment product that works this season with a breeding program that delivers permanent trait improvement. No competing platform in agricultural biotechnology integrates both.
Introducing OliSignal™ — our olive polyphenol signaling technology.
Every product Veos commercializes in agriculture is built on OliSignal™, our proprietary standardized olive polyphenol signaling technology. OliSignal™ is not fertilizer, not nutrition, not seaweed extract. It is a class of signaling molecules derived from Mediterranean olive by-products that activate the plant's own stress-response and growth pathways — before the stress event arrives.
This is the difference between feeding the plant and training it to survive a marathon. Both matter. Only the second one keeps the plant productive when conditions turn.
The world's first standardized olive polyphenol signaling platform for climate-resilient agriculture.
OliSignal™ is Veos's proprietary signaling technology — a standardized, circular, olive-derived molecular platform that primes plant defense and growth pathways. Every OliSignal™-powered product is circular (sourced from Mediterranean olive by-products), signaling-based (activates the plant's own pathways rather than supplying nutrients), and backed by completed field cycles with reported p-values. The platform is the source. The products are downstream.
How OliSignal™ works
One mechanism. Five convergent effects. Same signaling technology across the platform.
One platform. Two ways to deliver climate resilience.
Veos operates two parallel R&D tracks that share the same OliSignal™ foundation but deliver on different timescales. Track 01 treats existing crops this season and delivers immediate resilience. Track 02 uses OliSignal™ as selection pressure to identify the individual plants that respond most strongly, then crosses and propagates those top responders into new strains with permanently enhanced natural productivity under stress. The two tracks compound: growers can plant Veos Propello Genesis™ strains AND treat them with BioPropello™.
BioPropello™
The world's first standardized olive-polyphenol signaling platform designed to improve crop resilience before stress occurs. Powered by OliSignal™. Applied topically to existing crops during the growing season.
Field-validated in cereals, legumes, and horticulture across four countries and four climate bands. Category-defining evidence: the only signaling platform with published stress-protein induction data.
Veos Propello Genesis™
A conventional breeding and selection program that uses OliSignal™ as selection pressure. Treat diverse populations with BioPropello, identify the strongest responders, cross them, propagate the seed, and breed for enhanced natural responsiveness.
The result: new plant strains that produce more naturally under stress AND respond more strongly when treated. Non-GMO. Non-transgenic. Non-CRISPR. No regulatory friction in EU, US, or emerging markets.
The two tracks, side by side
One works this season. The other works forever. Together they make an integrated climate-resilience platform.
Three staple crops. Three climate-vulnerable value chains.
The Veos Propello Genesis™ breeding program focuses on three crops that share a critical profile: they feed or fuel massive global value chains, they are severely threatened by climate change, and their existing genetics were not selected for the stress conditions they now face.
Genesis crops target over 4 billion people and more than $500 billion in annual agricultural value.
Because the breeding is 100% conventional — no GMO, no CRISPR, no transgenics — Veos Propello Genesis™ strains carry no regulatory restrictions in the EU, no import barriers in emerging markets, and no consumer resistance. The commercial pathway is open in every geography that matters.
Field-validated. Publication-grade.
Every claim on this platform traces back to primary data from named academic, private-farm, or government partners. The evidence base below shows the strongest single validations from three crop families — horticulture, legumes, and cereals. Full evidence table on the BioPropello page.
The economics. Not just the science.
Growers, cooperatives, distributors, and seed companies adopt Veos platform products because the underlying economics work — not because the science is interesting. Below are the value drivers our commercial partners cite most frequently.
Earlier harvest
Green bean cycle: 11 days earlier first yield. Shifts the crop into market ahead of price compression.
Higher survival
Green bean stress trial: 100% vs 0% survival at D40. Growers keep the crop when neighbors lose theirs.
Reduced crop losses
Under abiotic stress, primed crops hold. This is the largest single ROI driver in stress years.
Higher and more stable yield
Parsley ×7.6 biomass. Green bean 4.7× yield. Cereal germination doublings. Real fields, not lab conditions.
Better ROI per hectare
$108 input → $350–580 net income gain per hectare. 3–5× payback per season. Compounds in stress years.
Reduced fertilizer dependency
Primed plants absorb inputs more efficiently. Field evidence supports ~20% fertilizer reduction. Full validation ongoing.
One row nobody else can check. Every row.
Every agricultural input on the market today is either a fertilizer (nutrition) or a generic biostimulant (loosely characterized botanicals). Veos is neither. The OliSignal™ platform is the only entrant with signaling-based mechanism, circular sourcing, proteomics-grade evidence, and integrated breeding.
| Traditional Fertilizer | Generic Biostimulant | Veos OliSignal™ | |
|---|---|---|---|
| Mechanism of action | Nutrition | Unknown / claimed | Signaling · documented |
| Circular sourcing | — | Sometimes | ✓ |
| Proteomics evidence | — | — | ✓ |
| Field-validated full cycles | Limited | Limited | ✓ |
| Climate-resilience platform | — | — | ✓ |
| Breeding-program integration | — | — | ✓ |
Field programs live now.
Veos Agriculture runs concurrent field programs across four countries, three continents, and four climate bands — combining commercial field trials, academic research partnerships, and government deployments. Each program contributes data back to the shared OliSignal™ evidence base.
FIG-FIELD-2026-BP02
Full-cycle field trial testing butterhead lettuce, snow pea, sugar pea, and a strawberry sub-trial. Day 4 early emergence: 80 treated seedlings vs 0 control in butterhead lettuce. Data accumulating through harvest.
Texas A&M AgriLife Research
Tier-1 US agricultural research institution validated the platform across three cereal species: corn +35.3% (p = 0.0077), sorghum +48.7% (p < 0.0001), rice culm growth +90%. Confirms the mechanism generalizes.
Agri Connect Japan Partnership
€86K EU Innowwide grant (ID 2025-25398) for a 6-month Japan feasibility study on the OliSignal™ platform. Agri Connect Japan is subcontractor. FAMIC pre-consultation dossier built for Japan regulatory entry.
R&D Healthcare Canada
Commercial partnership for North American market entry. Canada's Fertilizers Act fast-track pathway offers a low-friction route into North America. R&D Healthcare Canada acts as commercial partner and regulatory navigator.
University of Málaga
Protocol development and stress-resilience characterisation in the Mediterranean climate band. Arabica coffee pilot in preparation as part of the Veos Propello Genesis™ program foundation work.
Kenya Government Partnership
East African deployment on maize and staples in partnership with local government and Islamic Relief Kenya. Establishes the replicable template for emerging-market scaling across sub-Saharan Africa.
Named collaborators. Every claim traceable.
Every OliSignal™-powered result traces back to primary data generated with named academic, private-farm, government, or commercial partners across six geographies.
Texas A&M AgriLife Research
Ferme Innovante Ghassan
University of Málaga
Agri Connect Japan
R&D Healthcare Canada
Local Government / IRK
Direct. License. Scale.
Sequential three-phase model: direct sales and seed-company partnerships in the near term; licensing and bulk supply agreements across the EU in the mid term; geographic expansion into US, LATAM, and MENA in the long term. Yield-share and royalty models on flagship cereal partnerships.
Direct sales & seed-company partnerships
Direct sales of BioPropello™ to agribusinesses and distributors. Partnerships with seed companies and large-scale farms across EU. Japan market entry via Innowwide feasibility. First Veos Propello Genesis™ selections advancing.
Licensing & bulk supply
Licensing and bulk supply agreements for BioPropello™ across EU, Japan, and Canada. Distributor exclusivities by geography and crop. Genesis rice and coffee strains entering multi-generation trials with commercial partners.
Geographic expansion & Genesis commercialization
Expansion into US, LATAM, and MENA. Scale platform revenues to $50M with CAGR > 100%. Yield-share and royalty models on flagship cereal partnerships. Genesis strains commercialization via seed licensees.
Veos operates three platforms. Explore the others.
Human Health
Consumer and OTC health platforms including ThymoTropin™ (TRPV3 activation for muscle preservation), Ocufresh® ophthalmic care, and a portfolio of ~40 commercialized products across the EU, US, and Canada.
Explore Human Health →Environmental Systems
OliQuell™ bio-catalytic water treatment and industrial air remediation platform. CE-marked, Spanish patent-protected, validated in pilots with Volvo, Zeekr, and IMDEA Madrid. Same olive-derived source materials.
Explore Environmental →Veos is building the world's first integrated climate-resilience platform combining stress priming, conventional breeding, and circular agricultural biotechnology.
Veos Agriculture is open to strategic deployment.
We partner with seed companies, large-scale farm operators, EU and MENA distributors, agricultural cooperatives, coffee and cacao roasters and manufacturers, and governments building climate-resilient food systems. Contact us to request the technical dossier, field-trial data, or discuss licensing territories and Genesis strain access.
OliSignal™, BioPropello™, and Veos Propello Genesis™ are trademarks of Veos Pharmaceuticals, S.L. BioPropello patent applications pending in the United States, the European Union, and via the Patent Cooperation Treaty (PCT). BioPropello CE-marked under Regulation (EU) 2019/1009 (fertilising products); FIFRA-exempt under 40 CFR 152.6(g) in the United States. Veos Propello Genesis™ is a conventional plant breeding program — strains developed are non-GMO, non-transgenic, and not derived from gene-editing techniques.
© 2026 Veos Pharmaceuticals, S.L. — CIF B10704534 · Madrid, Spain.